Forbes: AI In Healthcare Still Has A Long Journey Ahead

Healthcare has been promised a vast improvement by artificial intelligence (AI) technology for many years. With AI’s promise to increase access to and understanding of data, provide better navigation of patient care, or better decipher new research and development efforts, healthcare pundits have eagerly anticipated its mainstream adoption. In the hopes of improving the usability and quality of AI in their respective fields, many companies have invested billions of dollars. In the space of innovation and building, these efforts have yielded a lot of useful results. However, the technology still has a long way to go, Forbes concludes. It has been a challenge to cultivate reliable data sets to use as teaching models in the development of AI technology in healthcare. AI technology uses vast sets of data to decipher patterns and make recommendations. When dealing with patient care data, these recommendations and pattern recognition outputs are only as good as the data sets provided.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner